CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
repetitive Transcranial Magnetic Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05472870
NCT05472870N/ACompleted
CompareCT.gov

Efficacy and Mechanism of Repeated Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorder: an Open-label Clinical Trial(Ⅱ)

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine·interventional·Posted Jul 25, 2022·Updated Aug 21, 2024

In Brief

A clinical study evaluating repetitive Transcranial Magnetic Stimulation for Autism Spectrum Disorder. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study is a open-label clinical trial involving over 30 ASD children aged ≥4 years old. During the study, subjects received repeated transcranial magnetic stimulation (rTMS) intervention on the left primary motor cortex (M1) 10 times per day for 5 consecutive days and complete clinical assessments from pre-intervention to post-intervention. This study hopes to explore whether accelerated continuous theta-burst stimulation (a-cTBS) over left primary motor cortex (M1) can improve clinical symptoms of children with ASD in China.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesChina
CollaboratorsShanghai Mental Health Center

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 25, 2022
Enrollment StartJul 12, 2022
Primary CompletionDec 15, 2022
Study CompletionJan 20, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.9 years ago

Interventions

repetitive Transcranial Magnetic Stimulationdevice

A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the cerebral cortex.